University of Florence, Department of Internal Medicine, Viale Morgagni 85, 50134 Florence, Italy.
Expert Opin Ther Targets. 2010 Jul;14(7):759-74. doi: 10.1517/14728222.2010.497143.
IL-23 is one of the most intriguing cytokine for its many immunological functions, which are the basis of its important role in host defense but also of its possible contribution to the pathogenesis of several diseases.
The literature and patents about IL-23 pathway and their targeting in therapeutic potential applications. Findings published within the last 5 years receive particular attention.
An overview of the emerging role of IL-23 in physiological and pathological conditions and a review of the different approaches (IL-23 pathway-based) currently used for autoimmune diseases and cancer therapies and the results obtained both in preclinical models and in clinical trials.
Inhibition/targeting of IL-23 may be a good and novel therapeutic strategy, especially in the treatment of diseases like psoriasis, for which current treatments show more pronounced side effects than those of IL-23-blocking and employed as part of specific patient-tailored therapies in inflammatory bowel diseases.
IL-23 是最有趣的细胞因子之一,因其具有许多免疫学功能,这些功能是其在宿主防御中重要作用的基础,但也可能对多种疾病的发病机制有贡献。
关于 IL-23 途径及其在治疗应用中的靶向作用的文献和专利。特别关注过去 5 年内发表的研究结果。
了解 IL-23 在生理和病理条件下的新作用,以及目前用于治疗自身免疫性疾病和癌症的不同方法(基于 IL-23 途径),以及在临床前模型和临床试验中获得的结果。
IL-23 的抑制/靶向可能是一种很好的新治疗策略,特别是在治疗银屑病等疾病方面,与 IL-23 阻断相比,目前的治疗方法显示出更明显的副作用,并作为炎症性肠病等特定患者定制治疗的一部分。